Eastman Chemical (NYSE:EMN) Given Consensus Rating of “Moderate Buy” by Analysts

Shares of Eastman Chemical (NYSE:EMNGet Free Report) have received a consensus recommendation of “Moderate Buy” from the thirteen analysts that are currently covering the firm, Marketbeat.com reports. Six investment analysts have rated the stock with a hold rating and seven have given a buy rating to the company. The average 1 year price objective among brokerages that have issued a report on the stock in the last year is $113.54.

Several brokerages have recently weighed in on EMN. Barclays decreased their target price on shares of Eastman Chemical from $111.00 to $108.00 and set an “equal weight” rating for the company in a research note on Monday, February 3rd. StockNews.com raised shares of Eastman Chemical from a “hold” rating to a “buy” rating in a research report on Saturday, January 18th. Royal Bank of Canada lifted their target price on Eastman Chemical from $101.00 to $103.00 and gave the stock a “sector perform” rating in a research report on Tuesday, February 4th. JPMorgan Chase & Co. increased their price target on Eastman Chemical from $110.00 to $112.00 and gave the company an “overweight” rating in a report on Monday, February 3rd. Finally, Piper Sandler dropped their price objective on Eastman Chemical from $105.00 to $102.00 and set a “neutral” rating on the stock in a report on Tuesday, January 7th.

Check Out Our Latest Analysis on Eastman Chemical

Insider Buying and Selling at Eastman Chemical

In other news, EVP Stephen Glenn Crawford sold 10,504 shares of the company’s stock in a transaction dated Tuesday, November 26th. The shares were sold at an average price of $105.00, for a total value of $1,102,920.00. Following the sale, the executive vice president now owns 47,287 shares of the company’s stock, valued at approximately $4,965,135. This represents a 18.18 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Also, SVP Julie A. Mcalindon sold 4,456 shares of the company’s stock in a transaction dated Tuesday, November 26th. The stock was sold at an average price of $105.84, for a total transaction of $471,623.04. Following the sale, the senior vice president now directly owns 4,403 shares in the company, valued at $466,013.52. This represents a 50.30 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders own 1.93% of the company’s stock.

Institutional Inflows and Outflows

A number of hedge funds have recently bought and sold shares of EMN. Franklin Resources Inc. raised its holdings in Eastman Chemical by 10.8% during the 4th quarter. Franklin Resources Inc. now owns 5,785,259 shares of the basic materials company’s stock worth $528,310,000 after purchasing an additional 565,821 shares during the last quarter. State Street Corp raised its stake in shares of Eastman Chemical by 1.4% during the third quarter. State Street Corp now owns 5,285,230 shares of the basic materials company’s stock worth $595,820,000 after buying an additional 70,692 shares during the last quarter. Massachusetts Financial Services Co. MA lifted its holdings in Eastman Chemical by 4.0% in the fourth quarter. Massachusetts Financial Services Co. MA now owns 2,843,506 shares of the basic materials company’s stock valued at $259,669,000 after buying an additional 109,316 shares during the period. Geode Capital Management LLC boosted its stake in Eastman Chemical by 1.7% in the fourth quarter. Geode Capital Management LLC now owns 2,832,593 shares of the basic materials company’s stock valued at $257,986,000 after acquiring an additional 48,491 shares during the last quarter. Finally, Raymond James Financial Inc. bought a new position in Eastman Chemical in the fourth quarter valued at approximately $150,537,000. 83.65% of the stock is currently owned by institutional investors.

Eastman Chemical Trading Up 0.6 %

Shares of EMN opened at $101.33 on Thursday. Eastman Chemical has a fifty-two week low of $81.00 and a fifty-two week high of $114.50. The stock has a fifty day moving average of $94.25 and a two-hundred day moving average of $100.17. The company has a debt-to-equity ratio of 0.80, a quick ratio of 0.78 and a current ratio of 1.52. The company has a market capitalization of $11.75 billion, a PE ratio of 13.19, a price-to-earnings-growth ratio of 1.24 and a beta of 1.44.

Eastman Chemical (NYSE:EMNGet Free Report) last announced its quarterly earnings data on Thursday, January 30th. The basic materials company reported $1.87 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.60 by $0.27. Eastman Chemical had a net margin of 9.65% and a return on equity of 16.40%. As a group, analysts forecast that Eastman Chemical will post 8.47 EPS for the current year.

Eastman Chemical Increases Dividend

The business also recently announced a quarterly dividend, which was paid on Wednesday, January 8th. Investors of record on Monday, December 16th were paid a $0.83 dividend. This represents a $3.32 annualized dividend and a dividend yield of 3.28%. The ex-dividend date was Monday, December 16th. This is a boost from Eastman Chemical’s previous quarterly dividend of $0.81. Eastman Chemical’s dividend payout ratio (DPR) is presently 43.23%.

About Eastman Chemical

(Get Free Report

Eastman Chemical Company operates as a specialty materials company in the United States, China, and internationally. The company's Additives & Functional Products segment offers amine derivative-based building blocks, intermediates for surfactants, metam-based soil fumigants, and organic acid-based solutions; specialty coalescent and solvents, paint additives, and specialty polymers; and heat transfer and aviation fluids.

Read More

Analyst Recommendations for Eastman Chemical (NYSE:EMN)

Receive News & Ratings for Eastman Chemical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Eastman Chemical and related companies with MarketBeat.com's FREE daily email newsletter.